Injection of Ranibizumab Versus Combination of Ranibizumab and Triamcinolone Acetate for (CRVO)
Condition(s):OphthalmopathyLast Updated:July 7, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):OphthalmopathyLast Updated:July 7, 2020Unknown status
Condition(s):Age-Related Macular DegenerationLast Updated:August 31, 2012Unknown status
Condition(s):Age-Related Macular DegenerationLast Updated:July 13, 2021Completed
Condition(s):Neovascular Age Related Macular DegenerationLast Updated:October 30, 2009Completed
Condition(s):Diabetic Macular EdemaLast Updated:October 5, 2018Completed
Condition(s):Choroidal NeovascularizationLast Updated:October 19, 2012Completed
Condition(s):Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)Last Updated:February 25, 2020Completed
Condition(s):Diabetic Retinopathy; Retinal DetachmentLast Updated:September 14, 2010Completed
Condition(s):Age-Related Macular DegenerationLast Updated:August 28, 2019Terminated
Condition(s):Diabetic Macular EdemaLast Updated:November 30, 2018Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.